Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part II. Clinical CharacteristicsFrontiers in genetics, 2022-03, Vol.13, p.849267-849267 [Peer Reviewed Journal]Copyright © 2022 Altschmiedova, Todorovova, Vrablik, and Ceska. ;Copyright © 2022 Altschmiedova, Todorovova, Vrablik, and Ceska. 2022 Altschmiedova, Todorovova, Vrablik, and Ceska ;ISSN: 1664-8021 ;EISSN: 1664-8021 ;DOI: 10.3389/fgene.2022.849267 ;PMID: 35368707Full text available |
|
2 |
Material Type: Article
|
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)Progress in cardiovascular diseases, 2023-07, Vol.79, p.2 [Peer Reviewed Journal]ISSN: 1873-1740 ;DOI: 10.1016/j.pcad.2023.03.001Digital Resources/Online E-Resources |
|
3 |
Material Type: Article
|
The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinionAtherosclerosis. Supplements, 2019-12, Vol.39, p.e1EISSN: 1878-5050 ;DOI: 10.1016/j.atherosclerosissup.2019.08.023 ;PMID: 31451336Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE studyFrontiers in cardiovascular medicine, 2023-06, Vol.10, p.1206551-1206551 [Peer Reviewed Journal]2023 Banach, Lewek, Pol, Rabczenko, Balanescu, Blaha, Ceska, Jankowski, Surma, Kolovou, Liberopoulos, Mitu, Mitu, Naji, Paragh, Popławska, Vrablik and Pella. ;2023 Banach, Lewek, Pol, Rabczenko, Balanescu, Blaha, Ceska, Jankowski, Surma, Kolovou, Liberopoulos, Mitu, Mitu, Naji, Paragh, Popławska, Vrablik and Pella. 2023 Banach, Lewek, Pol, Rabczenko, Balanescu, Blaha, Ceska, Jankowski, Surma, Kolovou, Liberopoulos, Mitu, Mitu, Naji, Paragh, Popławska, Vrablik and Pella ;ISSN: 2297-055X ;EISSN: 2297-055X ;DOI: 10.3389/fcvm.2023.1206551 ;PMID: 37404744Full text available |
|
5 |
Material Type: Article
|
The Role of Nutraceuticals in Statin Intolerant PatientsJournal of the American College of Cardiology, 2018-07, Vol.72 (1), p.96-118 [Peer Reviewed Journal]2018 American College of Cardiology Foundation ;Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jul 3, 2018 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2018.04.040 ;PMID: 29957236Full text available |
|
6 |
Material Type: Article
|
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)Creative Commons: Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) http://creativecommons.org/licenses/by-nc-nd/4.0 ;ISSN: 0033-0620 ;EISSN: 1532-8643 ;DOI: 10.1016/j.pcad.2023.03.001 ;DOI: 10.5167/uzh-257579Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by StatinsJournal of cardiovascular pharmacology and therapeutics, 2022-01, Vol.27, p.10742484221138284The Author(s) 2022 ;ISSN: 1074-2484 ;EISSN: 1940-4034 ;DOI: 10.1177/10742484221138284 ;PMID: 36420979Full text available |
|
8 |
Material Type: Article
|
Analysis of incidence and prevalence of cardiovascular risk factors and evaluation of their control in epidemiological survey in the Czech RepublicCentral European journal of public health, 2020-06, Vol.28 (2), p.114-119 [Peer Reviewed Journal]Copyright National Institute of Public Health Jun 2020 ;ISSN: 1210-7778 ;EISSN: 1803-1048 ;DOI: 10.21101/cejph.a5730Full text available |
|
9 |
Material Type: Article
|
Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?Current atherosclerosis reports, 2021-10, Vol.23 (10), p.57 [Peer Reviewed Journal]The Author(s) 2021 ;2021. The Author(s). ;ISSN: 1523-3804 ;EISSN: 1534-6242 ;DOI: 10.1007/s11883-021-00955-y ;PMID: 34345932Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Coronary heart disease and hormone replacement therapy - from primary and secondary prevention to the window of opportunityNeuro-endocrinology letters, 2012, Vol.33 Suppl 2, p.17-21 [Peer Reviewed Journal]ISSN: 0172-780X ;PMID: 23183504Full text available |
|
11 |
Material Type: Article
|
Oral but not transdermal estrogen replacement therapy reduced level of tissue factor pathway inhibitor: cross-over designed studyNeuro-endocrinology letters, 2006-10, Vol.27 (5), p.665-668 [Peer Reviewed Journal]ISSN: 0172-780X ;PMID: 17159824Full text available |
|
12 |
Material Type: Article
|
Changes in Hemostatic Variables Induced by Estrogen Replacement Therapy: Comparison of Transdermal and Oral Administration in a Crossover-Designed StudyGynecologic and obstetric investigation, 2008-01, Vol.65 (1), p.47-51 [Peer Reviewed Journal]2008 S. Karger AG, Basel ;2008 INIST-CNRS ;(c) 2008 S. Karger AG, Basel ;ISSN: 0378-7346 ;EISSN: 1423-002X ;DOI: 10.1159/000107492 ;PMID: 17713346 ;CODEN: GOBIDSFull text available |
|
13 |
Material Type: Article
|
Safety Evaluation of [alpha]-Lipoic Acid Supplementation: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Clinical StudiesAntioxidants, 2020-10, Vol.9 (10) [Peer Reviewed Journal]COPYRIGHT 2020 MDPI AG ;ISSN: 2076-3921 ;EISSN: 2076-3921 ;DOI: 10.3390/antiox9101011Full text available |
|
14 |
Material Type: Article
|
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) FoundationCardiovascular diabetology, 2019-06, Vol.18 (1), p.71, Article 71 [Peer Reviewed Journal]The Author(s) 2019 ;ISSN: 1475-2840 ;EISSN: 1475-2840 ;DOI: 10.1186/s12933-019-0864-7 ;PMID: 31164165Full text available |
|
15 |
Material Type: Article
|
Association between polymorphism within the RYR2 receptor and development of statin-associated myalgia/myopathy in the Czech populationEuropean journal of internal medicine, 2015-06, Vol.26 (5), p.367 [Peer Reviewed Journal]EISSN: 1879-0828 ;DOI: 10.1016/j.ejim.2015.02.019 ;PMID: 25753936Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Impact of apolipoprotein A5 variants on statin treatment efficacyPharmacogenomics, 2009-06, Vol.10 (6), p.945-950 [Peer Reviewed Journal]2009 © Future Medicine Ltd ;ISSN: 1462-2416 ;EISSN: 1744-8042 ;DOI: 10.2217/pgs.09.17 ;PMID: 19530961Full text available |
|
17 |
Material Type: Article
|
COQ2 polymorphisms are not associated with increased risk of statin-induced myalgia/myopathy in the Czech populationDrug metabolism and drug interactions, 2017-12, Vol.32 (4), p.177 [Peer Reviewed Journal]Copyright Walter de Gruyter GmbH 2017 ;ISSN: 0792-5077 ;EISSN: 2191-0162 ;DOI: 10.1515/dmpt-2017-0027Full text available |
|
18 |
Material Type: Article
|
The Gene Score for Predicting Hypertriglyceridemia: New Insights from a Czech Case–Control StudyMolecular diagnosis & therapy, 2019-08, Vol.23 (4), p.555-562Springer Nature Switzerland AG 2019 ;Copyright Springer Nature B.V. Aug 2019 ;ISSN: 1177-1062 ;EISSN: 1179-2000 ;DOI: 10.1007/s40291-019-00412-2 ;PMID: 31222479Full text available |
|
19 |
Material Type: Article
|
Effect of apolipoprotein E polymorphism on statin-induced decreases in plasma lipids and cardiovascular eventsDrug metabolism and drug interactions, 2011-05, Vol.26 (1), p.13-20ISSN: 0792-5077 ;EISSN: 2191-0162 ;DOI: 10.1515/dmdi.2011.107 ;PMID: 21557673Full text available |
|
20 |
Material Type: Article
|
Low prevalence of type 2 diabetes mellitus among patients with high levels of high-density lipoprotein cholesterolJournal of clinical lipidology, 2013-05, Vol.7 (3), p.194 [Peer Reviewed Journal]Copyright © 2013 National Lipid Association. Published by Elsevier Inc. All rights reserved. ;ISSN: 1933-2874 ;EISSN: 1876-4789 ;DOI: 10.1016/j.jacl.2013.02.003 ;PMID: 23725918Digital Resources/Online E-Resources |